|
|
Volumn 384, Issue 9957, 2014, Pages 1833-
|
|
First trials for Ebola treatments announced
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRINCIDOFOVIR;
FAVIPIRAVIR;
AMIDE;
NEW DRUG;
PYRAZINE DERIVATIVE;
ANTHROPOLOGY;
DRUG EFFICACY;
DRUG SAFETY;
EBOLA HEMORRHAGIC FEVER;
HUMAN;
MEDICAL RESEARCH;
NOTE;
PRIORITY JOURNAL;
SCIENTIST;
AFRICA;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
FEMALE;
FOLLOW UP;
HEMORRHAGIC FEVER, EBOLA;
MALE;
PATIENT SELECTION;
RISK ASSESSMENT;
TREATMENT OUTCOME;
AFRICA, WESTERN;
AMIDES;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
DRUGS, INVESTIGATIONAL;
FEMALE;
FOLLOW-UP STUDIES;
HEMORRHAGIC FEVER, EBOLA;
HUMANS;
MALE;
PATIENT SELECTION;
PYRAZINES;
RISK ASSESSMENT;
TREATMENT OUTCOME;
|
|
EID: 84920485507
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(14)62043-2 Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|
